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Background: The mechanoenergetic effects of atrioventricular delay optimization during biventricular
pacing (“cardiac resynchronization therapy”, CRT) are unknown.
Methods: Eleven patients with heart failure and left bundle branch block (LBBB) underwent invasive
measurements of left ventricular (LV) developed pressure, aortic ﬂow velocity-time-integral (VTI) and
myocardial oxygen consumption (MVO2) at 4 pacing states: biventricular pacing (with VV 0 ms) at AVD
40ms (AV-40), AVD 120ms (AV-120, a common nominal AV delay), at their pre-identiﬁed individualised
haemodynamic optimum (AV-Opt); and intrinsic conduction (LBBB).
Results: AV-120, relative to LBBB, increased LV developed pressure by a mean of 11(SEM 2)%, p=0.001, and
aortic VTI by 11(SEM 3)%, p=0.002, but also increased MVO2 by 11(SEM 5)%, p=0.04.
AV-Opt further increased LVdeveloped pressure by amean of 2(SEM1)%, p=0.035 and aortic VTI by 4(SEM1)%,
p=0.017. MVO2 trended further up by 7(SEM 5)%, p=0.22.
Mechanoenergetics at AV-40 were no different from LBBB.
The 4 states lay on a straight line for Δexternal work (ΔLV developed pressure ×Δaortic VTI) against ΔMVO2,
with slope 1.80, signiﬁcantly N1 (p=0.02).
Conclusions: Biventricular pacing and atrioventricular delay optimization increased external cardiac work done
but also myocardial oxygen consumption. Nevertheless, the increase in cardiac work was ~80% greater than
the increase in oxygen consumption, signifying an improvement in cardiac mechanoenergetics. Finally, the
incremental effect of optimization on external work was approximately one-third beyond that of nominal AV
pacing, along the same favourable efﬁciency trajectory, suggesting that AV delay dominates the biventricular
pacing effect —which may therefore not be mainly “resynchronization”.© 2013 The Authors. Published by Elsevier Ireland Ltd. Open access under CC BY-NC-ND license. 1. Introduction
Atriobiventricular pacing (cardiac resynchronization therapy, CRT)
in heart failure patients with LBBB and EF b35%, has been shown in
small pioneering studies to increase arterial blood pressure and cardiac
output and increases external ventricular work [1–5] and efﬁciency [6].
Large randomized controlled trials later demonstrated reductions in
morbidity and mortality [7–10]. Some questions remain, however.
First, the effect of atriobiventricular pacing on myocardial oxygen
consumption per beat is not certain. One invasive study [6] whereCirculatory Health, St Mary's
2 1LA, UK. Tel.: +44 20 7594
.
land Ltd. Open access under CC BY-NCheart rate was allowed to vary spontaneously found that myocardial
oxygen consumption per minute fell after 2min of pacing (at 85.8±
4.5 bpm), but it is not clear whether oxygen consumption per beat
was altered.
Non-invasive measurement of myocardial oxygen consumption,
using positron emission tomography (PET), has shown favorable
regional redistribution of myocardial oxygen consumption after
biventricular pacing at several time points [11–13]. These studies
were carried out after 12 months of device implantation [11]
(with at least 2 h of ﬁxed heart rate pacing at +10 bpm above
sinus rhythm) and they too were at a non-ﬁxed heart rate, 70 ±
12 bpm after 4 months [12] and 65 ± 9 bpm after 13 months [13]
of implantation. All suggested a non-signiﬁcant trend to increase in
myocardial oxygen consumption. Moreover, DCM patients with LBBB
have lower myocardial oxygen consumption than those without [14].
Second, it is not known whether the pattern of mechanoenergetic
effect of AV delay adjustment resembles that of resynchronization itself
or has a different proﬁle. AV delay adjustment improves haemodynamic-ND license. 
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ﬁlling time, increasing stroke volume and cardiac output [15]. The
impact of AV delay is larger at higher heart rates, during exercise,
where diastolic time is shorter [15]. It is not known whether, once
the left ventricle has been resynchronized, there is any further
mechanoenergetic beneﬁt of AV optimization.
We designed one experiment to answer both questions invasively
by monitoring cardiac output, aortic and left ventricular pressures and
myocardial oxygen consumption, in a contemporary cohort of patients
undergoing biventricular pacing device implantation.
The primary endpoint was the detection with high resolution of the
effect of biventricular pacing at nominal AV delay on pressure, ﬂow
velocity, and myocardial oxygen consumption. The secondary endpoint
was detection of the incremental effect of changing from nominal AV
delay to a patient-individualized AV optimum, determined separately
beforehand to avoid inadvertent overestimation of effect size [16].
2. Methods
2.1. Study subjects
Sequential patients about to undergo coronary angiography as a routine part of
evaluation prior to implantation of a biventricular pacemaker were approached for
recruitment in this prospective study which was approved by the local ethics
committee. Each subject served as their own control. All twelve patients who
were consecutively approached prior to angiography gave consent for this study.
Patients were eligible if their coronary angiogram showed no current signiﬁcant
coronary artery stenosis requiring revascularisation. One patient was found to
have a signiﬁcant coronary stenosis and was therefore excluded; the 11 remaining
underwent the study. Patient characteristics are displayed in Table 1. All patients
were on an ACE inhibitor or angiotensin receptor blocker, ten were on diuretics
and none on digitalis. Four patients were not on beta blockers: two had signiﬁcant
chronic obstructive pulmonary disease and two patients had withdrawn from beta
blockers due to adverse symptoms they considered unacceptable [17].
2.2. Measurements
2.2.1. Patient preparation
Temporary biventricular pacing was established via the femoral route as follows; one
quadripolar electrode catheter (Josephson Curve, Bard Vikings) was positioned in the
standard high right atrium position and one pentapole electrode catheter (Josephson
Curve, Bard Woven) in the right ventricular apex.
Temporary LV pacing was established using an AL1 (Mach 1™ Guide Catheter Boston
Scientiﬁc Corporation) and/or a Channel Sheath (Bard® Channel Steerable Sheath) to gain
access to the coronary sinus and an ATW guidewire (Cordis Corporation) was positioned
in a lateral or posterior-lateral branch for LV pacing. This method of temporary unipolar
LV pacing achieves comparable QRS width to LV pacing with an over-the-wire Medtronic
lead (Medtronic 4193) at the same pacing site [18]. The exact placement of the LV pacing
wire was partly guided by its stability, by the presence of a late local electrogram relative
to the LBBB and absence of diaphragmatic capture.
The RA, RV and LV pacing leads were connected via custom made connectors to a
standard biventricular pacemaker (Medtronic InSync III 8042), Fig. 1. Left ventricular
capture was conﬁrmed with a 12 lead ECG recording. Stable sensing and pacing for all
three pacing wires were conﬁrmed and checked periodically throughout the study.Table 1
Characteristics of patients at baseline.
Patient Gender Age
(years)
Cause of
heart failure
NYHA
class
Heart
(bpm
1 M 52 DCM III 68
2 M 73 IHD III 73
3 M 60 IHD III 55
4 M 78 DCM IV 62
5 M 76 DCM III 83
6 M 80 IHD III 72
7 M 65 IHD III 52
8 F 62 DCM IV 70
9 M 68 DCM III 60
10 M 42 DCM III 64
11 M 64 DCM III 68
Mean 65 66
St.Dev. 11 92.2.2. Stage I: Establishment of non-invasive haemodynamic AV delay optimum
A non-invasive beat-to-beat blood pressure measurement device (Finapres Medical
Systems, Amsterdam, Netherlands) was applied to the patient's ﬁnger. In all patients,
heart rate was kept ﬁxed by atrially pacing at 100 bpm. Throughout the study, the VV
delay was kept at 0ms.
Non-invasive haemodynamic AV delay optimization was carried out using an
alternation algorithm as previously described [19–23]. In brief, a series of AV delays
were tested and compared against a reference AV delay (120 ms) using several
forward and backward transitions, which allowed the relative systolic blood pressure
difference between the AV delays to be determined to a high level of precision
[19,24–26]. We tested a range of AV delays for each patient (40, 80, 160, 200, 240,
and so forth at 40 ms intervals) until intrinsic conduction was reached. The non-
invasive haemodynamic optimal AV value was deﬁned for each individual as the AV
delay corresponding to the maximum of the parabola ﬁtted to the measured systolic
blood pressure [19,20]. This alternation protocol is semi-automated and an optimal
AV delay can be determined within a fewminutes as shown in Fig. 2. The curve ﬁtting
process identiﬁes the optimum as a continuous variable, without restricting it to
being one of the tested settings [27].2.2.3. Stage II: Invasive measurements at 4 pacing settings
(a) A pressure wire (Volcano PrimeWire 7900) was placed in the LV cavity via a
diagnostic catheter and was used to record the LV pressure throughout the
cardiac cycle. The diagnostic catheter was withdrawn 4–5 cm into the aorta and
kept at this position throughout the study, leaving the pressure wire in the LV
cavity. A ﬂow wire (Volcano FloWire 1400) was then inserted into the same
diagnostic catheter and carefully positioned in the aorta, approximately 4 cm
from the aortic valve to obtain a stable ﬂow velocity signal. The positions of the
diagnostic catheter and the pressure and ﬂowwires were conﬁrmed periodically
throughout this stage of the procedure.
Measurements of aortic ﬂow velocity and LV pressure were made at a ﬁxed atrial
rate (100 bpm) in random order, at 4 pacemaker settings: AVD 40ms (AV-40);
reference AVD 120 ms (AV-120, a commonly programmed nominal AVD),
the individual's predetermined (as described in Stage I above) non invasive
haemodynamic optimum (AV-Opt) and AAI (intrinsic ventricular conduction
i.e. LBBB).
Note that the AV-Opt was determined during stage I, i.e. using only non-
invasive pressure measurements. Therefore the data obtained in stage II
with this pacemaker setting does not simply represent the highest value of
any stage II measurement, rather it represents the invasive haemodynamic
values arising as a consequence of the pacemaker being programmed to the
optimal setting identiﬁed by non invasive haemodynamics.
Invasive left ventricular pressure and aortic ﬂow velocity were measured
after a steady state pacing period of 90 s at all 4 pacing states. The product
of aortic ﬂow velocity integral and left ventricular developed pressure
(systolic – diastolic) was used as an index of stroke work for each AV delay
tested to enable comparison of all four tested pacing states.
(b) For the invasive assessment of myocardial oxygen consumption the ﬂowwire
was then repositioned, through a diagnostic catheter, in the left coronary
artery in a proximal position where a clear Doppler signal could be recorded.
The site was the left main stem in 10 patients, but had to be the proximal
circumﬂex artery in 1 patient. The velocity waveform was traced automatically
(by the ComboMap console Pressure and Flow system), and this proﬁle of the
velocity waveform was digitally acquired by our system for automatic ensemble
averaging across beats, to obtain a velocity-time integral for all the four pacing
states testedwithin each patient.Myocardial oxygen consumptionwas estimated
by multiplying arteriovenous oxygen saturation difference, ΔAVO2, (in the left
coronary artery and coronary sinus) by coronary ﬂow velocity-time integral.rate
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Fig. 1. Experimental setup depicting the typical position of the three pacing wires (in the standard high right atrium, right ventricular apex and posterior/posterolateral coronary sinus
branch). The Finometer was used for non-invasive haemodynamic AV delay optimization during stage I. In stage IIa, invasive measurements of aortic ﬂow velocity and left ventricular
pressure measurements were recorded at the 4 pacing states (AV delay of 40ms, 120ms, and the predetermined optimal AV delay; and LBBB) and their product was used for estimation
of external cardiac work.
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withdrawn, for saturation assessment, after at least 90 s of pacing in that state [6,28,29].
Coronary ﬂow was deﬁned as the velocity-time integral averaged over the 60 s period of
blood sample withdrawal.
2.3. Data acquisition
Aortic and coronary ﬂow velocities and coronary and left ventricular pressures were
measured by the sensor-tipped pressure and ﬂow wires. Aortic pressure was measured
using a standard ﬂuid-ﬁlled catheter which was carefully calibrated before the study
measurements, by matching against the pressure wire signal, with the pressure wire
and catheter co-located in the aorta. Haemodynamic and ECG data were acquired using
a NIDAQ AI-16E-4 analog-to-digital card (National Instruments, Austin, TX) and Labview
(National Instruments, Austin, TX). They were analysed with custom software based on
the Matlab platform (MathWorks, Natick, MA).
2.4. Statistics
Distributions of baseline characteristics are given as mean and standard deviation.
Statements regardingmean effect sizes are given asmean and its uncertainty, i.e. standard
error of the mean. Where space permits, both are presented.
Some of the physiological variables did not ﬁt the criteria for normal distribution on
the Anderson Darling test and therefore the pressure, ﬂow, MVO2 and cardiac work data
were log transformed, which produced variables that passed the normality test. Statistical
tests were therefore performed on the log transformed data using standard parametric
methods. Comparisons between the 4 pacing states were performed by repeated
measures ANOVA (on log transformedvalues) andwhere therewas evidence of difference
between groups this was pursued using individual t-tests.
The p-valueswere calculated comparisonwise [30,31] and the reader should be aware
that the risk of a false positive ﬁnding somewhere in the paper as a whole is higher than
5%. Stata version 11.0 for Windows (StataCorp LP, College Station, Texas) was used for
statistical analysis.The protocol was designed to avoid inadvertent exaggeration of effects [32,33] or
artiﬁcial correlations [34,35].3. Results
The individual patient data for all measurements made during the
study are displayed on Table 2. The changes in these haemodynamic
parameters, which occurred during biventricular pacing, at the
prespeciﬁed three AV delays, are presented on Table 3.
In Table A1 in the Appendix the raw values of all haemodynamic
parameters across all patients at the three biventricular pacing states
are presented, to permit any alternative form of analysis.3.1. Effect of biventricular pacing on haemodynamics
Left ventricular developed pressure (systolic minus diastolic) rose
from LBBB to AV 120 ms (AV-120) by 11 (SD 8, SEM 2)%, p= 0.001,
and an additional 2 (SD 3, SEM1)% increasewas observed at the optimal
haemodynamic AV delay (AV-Opt); p=0.035 versus AV-120. At AVD
40ms (AV-40), developed pressure was worse than AV-120 (p b 0.001)
and not statistically different to LBBB (Δ=-2 (SD 11, SEM 3)%, p=0.50).
Aortic velocity time integral (index of stroke volume), measured
throughout each individual's study, rose by 11 (SD 9, SEM 3)% from
LBBB to AV-120, p = 0.002, rising a further 4 (SD 4 SEM 1)% at AV-
Opt, p=0.017 versus AV-120.
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Fig. 2. Protocol of AV optimization using the alternations concept. The data are presented as mean and standard error of the mean (SEM). In this example alternations were performed
between the reference AV delay (AV 120 ms) and the tested AV delay (AV 80 ms). A number of alternations are performed for each tested AV delay and this generates a number of
replicates of data (six in this example) which are then averaged and the mean change in non-invasive systolic blood pressure from the reference AV delay can be calculated. The more
replicates averaged (at the expense of more time required) the better the signal-to-noise ratio and therefore higher precision in identifying the true optimal AV delay. We have found
that reliable, reproducible optimization can be achieved in approximately 12min.
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different to LBBB (Δ= 1 (SD 10, SEM 3)%, p= 0.87). All four pacing
states are shown in Fig. 3.
During atriobiventricular pacing the relationship between Δaortic
VTI and ΔLV developed pressure, from LBBB, was characterized by theTable 2
AV conduction and haemodynamic parameters at an atrially paced rate (AAI) of 100 bpm.
Patient PR interval
with AAI
pacing (ms)
Optimal
AV delay
(ms)
Coronary
ﬂow VTI
(cm)
A-V oxygen sat
(%)
1 220 155 12 63
2 250 187 41 51
3 253 176 33 48
4 215 148 20 39
5 235 186 19 72
6 350 193 17 67
7 240 175 18 56
8 270 211 20 61
9 205 140 31 67
10 295 211 12 46
11 285 213 24 70
Mean 256 181 23 58
Stand. dev. 42 26 9 11
SEM 13 8 3 3regression equation, y = 1.140 x − 0.017. The slope, 1.14, was not
statistically different to 1 (p = ns); i.e. both parameters changed by
equal proportions.
Compared with LBBB, external cardiac work (indexed by aortic
VTI × LV developed pressure) increased at AV-120 by 24 (SD 20,uration Myocardial
oxygen cons.
index (au)
LV developed
pressure
(mmHg)
Aortic
VTI
(cm)
Cardiac
work index
(au)
753 83 22 1859
2092 128 12 1473
1622 140 22 3019
786 118 8 972
1379 129 14 1837
1102 85 14 1207
1036 90 19 1694
1229 112 14 1569
2089 133 22 2911
560 114 11 1237
1684 124 15 1849
1303 114 16 1784
523 20 5 652
158 6 1 197
Table 3
Relative changes (%) in haemodynamic parameters at 100 bpm, with LBBB as reference.
Patient Myocardial oxygen cons.
(% change from LBBB)
LV developed pressure
(% change from LBBB)
Aortic velocity time integral
(% change from LBBB)
Cardiac work
(% change from LBBB)
AVD-40 AVD-120 Opt-AVD AVD-40 AVD-120 Opt-AVD AVD-40 AVD-120 Opt-AVD AVD-40 AVD-120 Opt-AVD
1 −7 1 3 −4 5 4 −3 11 13 −7 16 18
2 −17 13 20 4 10 17 8 16 29 12 28 51
3 13 41 28 6 12 9 5 20 19 10 35 30
4 18 27 24 −3 14 16 −7 11 11 −10 26 29
5 −8 21 20 −13 7 8 2 10 17 −11 18 26
6 18 24 33 21 33 34 26 32 40 53 77 89
7 −10 0 11 −4 10 12 −10 3 3 −14 13 16
8 0 10 0 −11 6 8 −10 −2 2 −20 5 10
9 −11 −9 −6 8 14 16 5 13 11 14 29 29
10 17 −5 48 −12 7 16 −2 6 10 −13 13 28
11 −14 −1 15 −11 4 9 −4 5 8 −14 8 17
Mean −0.1 11.0 17.7 −1.7 11.1 13.6 0.9 11.3 14.9 0.0 24.3 31.1
Stand. Dev. 14 16 16 11 8 8 10 9 11 21 20 22
SEM 4 5 5 3 2 2 3 3 3 6 6 7
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at AV-Opt; p=0.012 versus AV-120. AV-40 was not different to LBBB
(Δ=0 (SD21, SEM 6)% p=0.76), Fig. 4.3.2. Myocardial oxygen consumption
The myocardial oxygen consumption increased from LBBB to AV-
120 by 11 (SD 16, SEM 5)% (p= 0.04) and to AV-Opt by 18 (SD 16,
SEM 5)%, p = 0.003; there was no signiﬁcant difference in the
myocardial oxygen consumption between AV-120 and AV-Opt, p =
0.22. The myocardial oxygen consumption between AV-40 and LBBB
was not signiﬁcantly different; Δ=0 (SD 14, SEM 3) %, p=0.83), Fig. 4.-5%
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than for example AV-120 (a commonly programmed AV delay when AV optimization is
resynchronization is offset.3.3. Mechanoenergetic effect of biventricular pacing
The 4 states lay on a straight line, because the (resynchronization)
increment from LBBB to AV-120 had the same direction as the effects
of adjustment of AV delay (between AV-40, AV-120, AV-Opt). This
common direction had a slope (percentage increment in external
cardiac work done per percentage increment inΔmyocardial oxygen
consumption) of 1.80, signiﬁcantly greater than 1 (p=0.02), Fig. 5.
4. Discussion
While biventricular pacing at AVD 120 ms (a common nominal
setting of biventricular pacing devices) increased external cardiac10% 15% 20%
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Fig. 4. Effect of biventricular pacing with three different AV delays on myocardial oxygen
consumption (top ﬁgure) and cardiac work (indexed by the product of LV developed
pressure and aortic velocity time integral – bottom ﬁgure), compared to intrinsic
conduction (LBBB). The data are presented as mean and standard error of the mean
(SEM). Myocardial oxygen consumption increases when paced with an AV delay of
120 ms (AV-120) and at the optimal AV delay (AV-Opt), compared to LBBB. Similarly,
but proportionally more, the cardiac work rises at AV-120 ms and AV-Opt; this rise is
approximately one-third higher at AV-Opt than at AV-120. AV-40 was not signiﬁcantly
different compared with LBBB.
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oxygen consumption. Fortunately, the proportionate increase in external
cardiac work was 80% more than that in oxygen consumption, which
indicates that the increment had a higher efﬁciency than baseline LBBB
function.
Second, moving from AVD 120ms to the individual's predetermined
AV optimum signiﬁcantly increased external cardiac work delivered
by approximately one-third with a trend to a further increase in
myocardial oxygen consumption. The trajectory of this further
increment from optimization was similar to that of switching the
biventricular pacemaker on at AVD 120ms.
Finally, setting a universally unfavourable AV delay (40ms) put the
mechanoenergetic proﬁle of biventricular pacing back to values closely
resembling LBBB, i.e. unfavourable AV delay alone fully reversed the
entire mechanoenergetic beneﬁt of cardiac resynchronisation.
4.1. Impact of biventricular pacing on myocardial oxygen consumption
Our study demonstrates that, when heart rate is kept ﬁxed and
therefore not inﬂuencing mechanoenergetics, biventricular pacing
with a nominal AV delay of 120ms increases the myocardial oxygen
consumption per beat. In principle, the acute effect of biventricularpacing only affects the timing of activation and cannot directly
manipulate the internal metabolism of sarcomeres or mitochondria
[36]. Poorer synchrony means wall movement is occurring at times
that are more different between sites. As a result, cavity pressure
developed is delayed and overall lower. If inward wall movement
at each local site is the same, then the total energy consumed by
inward movement over the whole (dyssynchronous) chamber
must be less. Of course, it is possible that the sum of local inward
movements is larger in a dyssynchronous heart, but it has to be
larger by more than the degree of fall in pressure developed, before
their mutual product – the leading determinant of metabolic cost –
can be higher than in the synchronous heart.
Resynchronization of the ventricular walls prevents substantial
segments from escaping with light duties [37] (i.e. contracting early,
at lower pressure and therefore lower metabolic cost, but without
usefully ejecting blood). This might be why biventricular pacing
increases myocardial oxygen consumption.
Positron emission tomography scanning data at ﬁxed heart rate
suggested that biventricular pacing raises oxidative metabolism in the
septum by 15%, with no signiﬁcant changes in the lateral or anterior
walls [11]. It is the septum which has the opportunity to contract early
at lower cavity pressures – and therefore at lower metabolic cost –
during LBBB. Canine MRI tagging studies also indicate that at the site
of pacing, early local contraction dramatically reduces local work done
[36].
Many interventions that increase work done by the heart, do so at
the expense of increasing myocardial oxygen consumption [38,39].
The concept that biventricular pacing might be unique, increasing
work done while reducing oxygen consumption [6], has therefore
been very attractive. The biventricular pacing element of that study
was conducted in 5 of 10 invasively studied patients (having started
with 11 and set aside one in whom sufﬁcient systolic pressure response
was not obtained). The characteristics of those patients were typical of
patients being considered for biventricular pacing at that time (2000),
namely almost exclusively non ischaemic dilated cardiomyopathy,
long PR interval (mean PR 196.5 ± 13.6 ms), wide QRS (mean QRS
179.1±3.4ms) and very low ejection fraction (mean EF 19.7±2.6%).
Such patients are – even now – widely considered to be ideal
candidates for biventricular pacing. Our own study's patients are
more typical of current cohorts undergoing implantation, namely a
mixture of ischaemic and non ischaemic cardiomyopathies, Table 1.
That study also differed from ours in that it allowed heart rate to
change naturally and attempted a statistical correction to simulate
the effect of there being no reﬂex fall in heart rate with biventricular
pacing. In contrast our study ﬁxed heart rate at 100 bpm. The
previous approach gives the answer to a question which might be
argued to be more clinically important: net effect (with reﬂex heart
rate response); in contrast our current approach gives the answer
to a more speciﬁc mechanistic question: pure direct cardiac effect
(without reﬂex heart rate response). Together with the difference
in patient populations, this procedural difference may explain the
superﬁcially different results of the two studies.
Although it may seem disappointing that biventricular pacing did
not reduce myocardial oxygen consumption, it should be remembered
that fall in myocardial oxygen consumption is not essential to make
the heart more efﬁcient. Nor should an intervention that makes the
walls of the left ventricle contract more simultaneously, against a
higher cavity pressure, automatically be expected to reduce oxygen
consumption.
4.2. Commonalities between biventricular pacing and adjustment of AV
delay
In our study, initiation of biventricular pacing raised cardiac
work by 24 (SD 20, SEM 6)% for an increment in myocardial oxygen
consumption of only 11(SD 16, SEM 5)%. This means that the
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Fig. 5.Relationship between the change in cardiacwork (indexed by the product of LV developed pressure and aortic velocity time integral) and change inmyocardial oxygen consumption
with biventricular pacing at each of the three AV delays (40ms (AV-40), 120ms (AV-120) and optimal AV (AV-Opt), from LBBB. The data are presented asmean and standard error of the
mean (SEM). The slope (Δcardiacwork÷Δmyocardial oxygen consumption) of the regression line is 1.80 (signiﬁcantly higher than 1, p=0.02), implying amore efﬁcientmyocardial state
with biventricular pacing, at AV-120 or AV-Opt, than in LBBB. Of the two higher-efﬁciency states, the AV-Opt generates one-third more ‘useful’ cardiac work than AV-120, p=0.012.
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behaviour of the myocardium in the native LBBB state.
Beyond biventricular pacing at the nominal AV delay of 120 ms,
programming AVdelay to the noninvasively determined haemodynamic
optimum gave a further signiﬁcant increment in cardiac work of 7 (SD 8,
SEM2)% (approximately an additional one-third of the effect of AV-120),
and a non-signiﬁcant increase in myocardial oxygen consumption
(Fig. 5).
Initiation of biventricular pacing has a combination of effects:
shortening AV delay and ventricular resynchronisation. Adjusting
programmed AV delay also has both potential effects because it not
only changes the timing of the ventricular pacing, but also the time
relationship between that ventricular pacing and any native con-
duction contributing to ventricular activation. The presence of
ventricular fusion, is sometimes obvious from a visible change in
surface ECG, but is sometimes occult. For this reason we cannot be
sure that improvements in acute haemodynamic measurements
occurring with adjustment of AV delay are not partly acting through
changes in ventricular synchronization.
Another mechanism which may explain the effects of biventricular
pacing is the minimization of the negative effect of diastolic ventricular
interaction. Ventricular resynchronization has been shown to improve
left ventricular diastolic volume and effective left ventricular end
diastolic pressure by decreasing the external constraint caused by the
diastolic ventricular interaction in heart failure [40]. This reduction of
constraint led to an improved preload-dependent stroke volume. AV
delay optimization may also play a part in improving haemodynamics
by (a) improving synchronization further by allowing fusion of
biventricular pacing and native conduction, leading to a lesser
external constraint and (b) by maximizing the volume of blood
ﬁlling the left ventricle therefore raising the stroke volume by the
Starling mechanism.
Regardless of the precise mechanism of effect of AV delay
changes on haemodynamics, an increase in cardiac performance
with anything less than a fully corresponding increment in oxygen
consumption is welcome.Moreover, it is striking that setting the AV delay too short, at 40ms,
effectively annuls all the mechanoenergetic effects of biventricular
pacing, back to a state equivalent to LBBB.
4.3. Clinical implications
First, the impact of AV optimization on the measured parameters in
this study was about one-third the effect of switching on biventricular
pacing a ﬁxed AV delay of 120ms. This estimate is statistically unbiased
because the effect size was measured invasively entirely separately
from the previous collected non-invasive data used for identiﬁcation
of the optimal AV delay [19]. Thus, the ﬁnding that invasive pressure
is higher at the optimum is not simply selection of the highest amongst
random variation [24] since, had this occurred, the subsequent invasive
measurements would not on average have been any higher than the AV
120 values.
Second, the effect of optimization had the same balance of hae-
modynamic effects (and same inclination to improved efﬁciency) as
nominal-programmed pacing itself, although smaller (an additional
increment of one-third of that of nominal pacing), and so we should
expect the same balance of morbidity–mortality beneﬁts but an
endpoint trial to verify this would need to be much larger (×9) than
the landmark biventricular pacing trials. A smaller effect size does not
mean lower cost-effectiveness, since optimization can bemuch cheaper
than the implant procedure.
Third, this study shows that selecting the wrong AV delay does very
large harm to haemodynamics. Although extreme mis-selection (AV
40 ms) is required to systematically abolish the haemodynamic
effect of biventricular pacing across the whole population, milder
mis-selection (i.e. getting only close to the true optimum) may still
substantially downgrade haemodynamic beneﬁt.
The downgrade of the beneﬁt resulting from a mis-selection of the
‘optimal’ AV delay, would be larger at higher than lower heart rates.
Increasing heart rate drastically reduces left ventricular ﬁlling time,
making precise timing of activation more crucial [20]. Current evidence
suggests that adjustment of AVdelaywith exercise improves the cardiac
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[41] and also in the biventricular pacing population [42]. The ﬁndings
from our study complements existing evidence by demonstrating for
the ﬁrst time that optimization of the AV delay at a higher heart rate
(100 bpm) further improves cardiac mechanics, along the same
favourable efﬁciency trajectory of biventricular pacing at a nominal
AV setting.
4.4. Study limitations
Our studywas an invasive study and the number of subjects was not
large. However, it was sufﬁcient to address the physiological question
being considered. Patients were heterogeneous in terms of aetiology
and drug therapy but we believe they are representative of con-
temporary biventricular pacing device recipients.
In this studywedidnot assess dyssynchronyusing echocardiographic
measures. This was based on our analysis of the reports of prediction of
response, which can be seen to exceed the mathematically plausible
limit [43]. The strong positive claims arose entirely in studies lacking
formal enrolment or blinding, and are contradicted by formally-
designed studies [43]. The ESC Guidelines for the diagnosis and
treatment of acute and chronic heart failure 2012 also now recognise
that mechanical dyssynchrony assessment is not a useful addition in
the selection process. We recruited patients undergoing clinical
device implantation based on LBBB.
All participants were atrially paced. This prevented reﬂex reduction
in heart rate which is a feature of biventricular pacing but had the
advantage that it allowed the direct mechanoenergetic consequences
of resynchronization and AV optimization on the cardiac cycle to be
studied unconfounded by changes in heart rate.
Our study, like others [6], focuses on measurements of ﬂow in
the left coronary artery and not the right coronary artery, and on
measurements of saturation in the coronary sinus which drains
almost all of the left coronary artery territory but not all of the
right coronary artery territory (a considerable part of which drains
directly into the chambers). Therefore the impact on oxygen con-
sumption in the right coronary artery territory is not assessed by
this study and – because of its signiﬁcant direct drainage – may be
difﬁcult to assess. This may not be a trivial concern, but PET scan
studies which can measure global blood ﬂow have suggested a trend
to an overall increase in the total blood ﬂow during biventricular pacing
[11–13].
We have not attempted, and do not intend, to assess improvement in
mortality fromoptimization. The data showed that themechanoenergetic
effect of optimization (away from AVD 120) is about one-third of that
elicited by implantation of the device. Therefore the most likely impact
on survival would be one-third of the 29% beneﬁt seen in CARE-HF, i.e.
~10%. However an optimization endpoint trial adequately powered to
conﬁrm this would need to be approximately 32 = 9 times the size of
an implantation endpoint trial.
5. Conclusions
Biventricular pacing increases useful cardiac energy output by
~80% more than the increase in myocardial oxygen consumption,
i.e. the increment has an improved efﬁciency. Optimization further
increases both, and in the same proportion. The trajectories of
effect on haemodynamic measurements of AV optimization and of
institution of nominal-AV biventricular pacing are therefore very
similar, to the extent that mis-selection of AV completely abolishes
the haemodynamic effects of biventricular pacing, rendering the
patient back to a mechanoenergetic status equivalent to intrinsic
LBBB. This suggests that AV delay is an important contributor to
the haemodynamic (and therefore clinical) beneﬁt of biventricular
pacing and AV optimization appears to extend this improvement by
approximately one-third.Supplementary data to this article can be found online at http://dx.
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